AVBP · ArriVent BioPharma, Inc.

$31.12 -0.02 (-0.06%) At close · Aug 27

Market Cap

$1.54B

49.31M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed	Type	Industry	Offering	Sold	Min. Invest.	Investors	Exemptions
2022-12-29	New	Biotechnology	$145,000,000	$109,999,989	—	17	06b
2022-02-14	Amendment	Biotechnology	$150,000,000	$150,000,000	—	10	06b
2021-06-23	New	Biotechnology	$90,000,000	$81,000,000	—	9	06b

Showing 1–3 of 3 filings

Key facts CIK 1868279 CUSIP 04272N102 13F (30d) 140 filings 140 filers Visit website Investor relations